von Tobias Borgers | Feb. 3, 2020 | Continuous Manufacturing
Merck will invest $275 million (250 million euros) in a new facility in Corsier-sur-Vevey, Switzerland. The Merck Biotech Development Center will be dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the Healthcare...
von Tobias Borgers | Jan. 29, 2020 | Wettbewerber
Investment von 250 Mio. Euro 29.01.2020 Der Darmstädter Pharmakonzern Merck will 250 Mio. Euro in eine neue Anlage in Corsier-sur-Vevey in der Schweiz investieren. Das sogenannte „Biotech Development Center“ soll sich der Entwicklung und Herstellung biotechnologischer...
von Tobias Borgers | Jan. 27, 2020 | Continuous Manufacturing
„This investment in the Merck Biotech Development Center reflects our commitment to speed up the availability of new medicines for patients in need, and confirms the importance of Switzerland as our prime hub for the manufacturing of biotech medicines,“...
von Tobias Borgers | Jan. 14, 2020 | Continuous Manufacturing
3C Packaging3M Drug Delivery SystemsA Davies Laboratories LtdA&A CoatingsA+ Secure PackagingA.C. CompactingAaron Kendell Packaging (AEK)AB BioTechnologies, Inc.AB ControlsAbbVie Contract ManufacturingABICH SrlABL IncAbon Pharmaceuticals, LLCABOX Automation...
von Tobias Borgers | Jan. 6, 2020 | Tablet Coating
The global Sugar Coated Tablets Market report by wide-ranging study of the Sugar Coated Tablets industry which covers comprehensively all aspects of the different industry verticals. This includes its past performance analysis, latest market performance estimation for...
